Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Sleep Cycle AB in connection with the listing on Nasdaq Stockholm
Mandate

Vinge advises Sleep Cycle AB (publ) in connection with the listing on Nasdaq Stockholm

June 08, 2021 Capital Markets and Public M&A M&A Corporate Tax Intellectual Property Employment and Benefits

Vinge advises Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”) in connection with the listing on Nasdaq Stockholm. The offering circular was published on 28 May 2021 and the first day of trading on Nasdaq Stockholm was 8 June 2021.

The offering price was SEK 70 per share, corresponding to a market value of Sleep Cycle of approximately SEK 1.3bn. The offering comprised 4,870,171 shares, of which 1,428,571 are newly issued shares and 3,441,600 are existing shares.

Sleep Cycle is a market leading sleep tracking application with a mission to empower people to sleep better to improve global health. Sleep Cycle uses a patented AI-based audio technology to measure users’ sleep and provide personalized insights based on the Company’s sleep database. Sleep Cycle was founded in 2009 and is headquartered in Gothenburg, Sweden.

Vinge’s team mainly consisted of Jesper Schönbeck, Linnéa Sellström, Joel Magnusson and Lorin Arabi (Capital Markets and Public M&A), Matthias Pannier, Vilhelm Rondahl and Mikaela Falkner (M&A), Victor Ericsson, Henrik Wastenson and Jonathan Riddersholm (Corporate tax), Stojan Arnestål and Felizia Wiker (IP) and Ebba Svenburg (Employment and Benefits).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026